TABLE 3

Absorbed Doses of ¹⁸F-FAZA to Target Organs at Various Voiding Intervals

	¹⁸F-FAZA
Target organ	At 2 h	At 4 h	¹⁸F-FMISO at 2 h (19)	¹⁸F-FETNIM at 2 h (24)	¹⁸F-EF5 at 2.5 h (26)
Adrenals	0.012 ± 0.001	0.012 ± 0.001	0.017	0.012	0.014
Brain	0.004 ± 0.001	0.004 ± 0.001	0.009	0.006	0.012
Breasts	0.009 ± 0.001	0.009 ± 0.001	0.012	0.007	0.009
Gallbladder wall	0.013 ± 0.004	0.013 ± 0.004	0.015	0.014	0.055
Lower large intestine wall	0.013 ± 0.006	0.013 ± 0.006	0.014	0.012	0.017
Small intestine	0.012 ± 0.005	0.012 ± 0.005	0.013	0.012	0.015
Stomach wall	0.012 ± 0.001	0.012 ± 0.001	0.013	0.012	0.013
Upper large intestine wall	0.013 ± 0.002	0.013 ± 0.002	0.014	0.014	0.015
Heart wall	0.018 ± 0.001	0.018 ± 0.001	0.019	0.011	0.022
Kidneys	0.017 ± 0.002	0.017 ± 0.002	0.016	0.027	0.025
Liver	0.016 ± 0.003	0.016 ± 0.003	0.018	0.024	0.023
Lungs	0.011 ± 0.008	0.011 ± 0.008	0.010	0.008	0.017
Muscle	0.011 ± 0.009	0.011 ± 0.009	0.014	0.012	0.012
Ovaries	0.014 ± 0.001	0.014 ± 0.001	0.018	0.013	0.017
Pancreas	0.013 ± 0.002	0.013 ± 0.002	0.018	0.019	0.014
Red marrow	0.011 ± 0.001	0.011 ± 0.001	0.011	0.012	0.022
Bone surface	0.011 ± 0.002	0.011 ± 0.002	0.008	0.011	0.021
Skin	0.008 ± 0.001	0.008 ± 0.001	0.005	0.007	0.008
Spleen	0.017 ± 0.008	0.017 ± 0.009	0.016	0.020	0.012
Thymus	0.011 ± 0.003	0.011 ± 0.001	0.016	0.009	0.011
Thyroid	0.010 ± 0.001	0.010 ± 0.001	0.015	0.009	0.011
Urinary bladder wall	0.047 ± 0.008	0.067 ± 0.007	0.021	0.062	0.017
Uterus	0.020 ± 0.001	0.021 ± 0.001	0.018	0.015	0.023
Testes	0.004 ± 0.001	0.005 ± 0.001	0.015	0.010	0.013
Total body	0.012 ± 0.002	0.012 ± 0.002	0.013	0.011	0.014
Effective dose equivalent (mSv)	0.015 ± 0.004	0.017 ± 0.004	0.013	0.017	0.029
Effective dose (mSv)	0.013 ± 0.004	0.014 ± 0.004	—	0.015	0.023

Data are mGy/MBq (either mean or mean ± SD; n = 5 patients).